TABLE 4.
Operon structure | mRNA ratioa |
|||
---|---|---|---|---|
uidA | mtaA | mtaC | mtaB | |
PmcrB(tetO1)-uidA | 1.0 ± 0.2 | NAb | NA | NA |
PmcrB(tetO1)-mtaC3B3A1 | NA | 9.5 ± 2.1 | 9.5 ± 2.7 | 9.9 ± 3.3 |
PmcrB(tetO1)-mtaC2B2A1 | NA | 10.3 ± 1.7 | 15.2 ± 6.8 | 13.6 ± 5.8 |
PmcrB(tetO1)-mtaC1B1A1 | NA | 8.8 ± 2.6 | 7.9 ± 2.1 | 8.9 ± 2.3 |
PmcrB(tetO1)-mtaC1B1A2 | NA | 9.2 ± 2.2 | NDc | ND |
The ratios of mRNA levels from strains grown on methanol to mRNA levels from strains grown on TMA are shown. mRNA abundance was determined by qRT-PCR as described, by using total RNA isolated from strains WWM82 [PmcrB(tetO1)-uidA], WWM184 [PmcrB(tetO1)-mtaC3B3A1], WWM170 [PmcrB(tetO1)-mtaC2B2A1], WWM176 [PmcrB(tetO1)-mtaC1B1A1], and WWM181 [PmcrB(tetO1)-mtaC1B1A2] grown on either HS-methanol or HS-TMA. Tetracycline was added to all cultures to induce expression from the PmcrB(tetO1) promoter. All primers used in this experiment are listed in the supplemental material.
NA, not applicable.
ND, not determined.